CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 220 enrolled
Drug / intervention
Urgent PC Neuromodulation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00771264
NCT00771264Phase 4Completed
CompareCT.gov

Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms

Uroplasty, Inc·interventional·Posted Oct 13, 2008·Updated Apr 18, 2012

In Brief

A Phase 4 clinical trial evaluating Urgent PC Neuromodulation System for Overactive Bladder. Completed, enrolled 220 participants across 15 sites.

Detailed Summary

The purpose of this study is to demonstrate superiority of percutaneous posterior tibial nerve stimulation (PTNS) therapy compared to sham therapy for the treatment of patients with overall bladder (OAB) symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOveractive Bladder
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 13, 2008
Enrollment StartSep 1, 2008
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.7 years ago

Interventions

Urgent PC Neuromodulation Systemdevice

The Urgent PC Neuromodulation System is a minimally invasive neuromodulation system designed to deliver retrograde access to the sacral nerve through percutaneous electrical stimulation of the tibial nerve. The method of treatment is referred to as Percutaneous Tibial Nerve Stimulation (PTNS).